about
Topical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisChemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15Immunophenotype lymphocyte of peripheral blood in patients with psoriasis.Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severityBiological therapies in the systemic management of psoriasis: International Consensus Conference.Biological therapy for psoriasis.Biologic therapeutics in the treatment of psoriasis. Part 1: review.Novel immunobiologics for psoriasis.Topical treatments for chronic plaque psoriasis of the scalp: a systematic review.Comparisons of gene expression in normal, lesional, and non-lesional psoriatic skin using DNA microarray techniques.Biological markers in the etiology of psoriasis: Targeted treatment options.Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.Pathogenesis of psoriasis and current challenges.Xiaoyin recipe ( ) for psoriasis induces a Th1/Th2 balance drift toward Th2 in peripheral blood mononuclear cells of experimental autoimmune thyroiditis rats.Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimodEfalizumab in the Treatment of Psoriasis
P2860
Q24198258-7CE7D64F-57B7-48BC-A9ED-6AD1404AE9A7Q24241239-35B8D69B-F208-4E70-898B-1DE8136A1FC0Q24310573-DDAAEE1B-5084-4203-B7B9-69B7E332F95DQ34557120-1C0122CF-097D-4E44-8A4F-BEDEDEB06CC6Q34945351-92B4413F-1359-40D4-AB8B-EFF73FE9E2CDQ35841615-3469E641-EA13-4DAF-801F-04B5E25FAEDDQ36471426-9D4A45AF-5E75-48D0-89C7-0E7366168953Q36826201-72D6E96C-E30F-42A9-B319-41F352FCAD1DQ37664478-9C717422-0A54-41DA-B3CA-148AA60871AAQ38116596-0657C47F-52C5-4169-9FD2-17DBCD85E2F2Q38474670-18F88001-A923-4B7A-95A2-9E2AB7E13FC5Q43078162-0126F926-B5E5-4C4A-9165-6F7DC55EC36BQ46574517-248C4973-2CBB-45EF-A379-0885AAABA3BBQ51045110-26FA61A2-980B-4FE0-A5DA-19F10CAE516AQ53312205-CDBCD6CF-185F-4705-B77B-ADA0266A08A4Q54325409-18C81CCE-6AF6-4AFB-BB97-F0234ADEA5B1Q56679622-FF40F843-72E8-4896-8C92-BC27D6C5F4EFQ58404187-86802845-3822-41F5-B379-AAF8F0A8D121
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The immunological basis of psoriasis.
@ast
The immunological basis of psoriasis.
@en
type
label
The immunological basis of psoriasis.
@ast
The immunological basis of psoriasis.
@en
prefLabel
The immunological basis of psoriasis.
@ast
The immunological basis of psoriasis.
@en
P2860
P1476
The immunological basis of psoriasis.
@en
P2093
Griffiths CE
P2860
P356
10.1046/J.1468-3083.17.S2.1.X
P478
17 Suppl 2
P577
2003-07-01T00:00:00Z